- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05088590
Growing Up Formula Versus Nutritional Supplements: Effect on Catch up Growth, Micronutrient Status, and Solid Foods Intake in Toddlers With Mild or Moderate Malnutrition (KEEP Growing)
February 13, 2025 updated by: University of Colorado, Denver
This is a pilot study to test how a growing-up formula (GUF) compares to a common nutritional supplement (NS), which is regularly used to help toddlers (ages 12-36 months) gain weight.
This study will look at whether GUF helps to increase solid food intake for children who are thought to be "picky eaters" and see the effects on growth compared with the NS.
To date, it is not clear if GUFs help to increase intake of solid foods.
Participants will be placed into one of the two study arms: Enfagrow (GUF) or Pediasure (standard NS).
Study Overview
Status
Completed
Study Type
Interventional
Enrollment (Actual)
41
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- Children's Hospital Colorado
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 3 years (Child)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
Healthy toddlers 12-36 months of age with mild or moderate malnutrition will be defined by at least one of the following indicators:
- Weight-for-length z-score between -1.0 and -2.9 for children less than 2 years of age using the WHO growth standards; or
- BMI z-score between -1 to -2.9 for children between 2 and 3 years of age using the CDC growth standards; or
- Middle upper-arm circumference (MUAC) z-scores between -1 to -2.9 using the WHO growth references; or
- Percentage of median ideal body weight of 70-89% (using the 50th percentile of the aforementioned growth standards).
Exclusion Criteria:
- Toddlers currently on or with history of tube feeding or with chronic health conditions that influence eating (e.g., food allergies, genetic disorders or developmental disabilities, oral motor difficulties that require sensory or feeding therapy).
- Toddlers who were born at less than 34 weeks gestation, as they may have lingering feeding challenges.
- Toddlers with gastroesophageal reflux disease (GERD) requiring medications or hydrolyzed formula or any type of esophageal disorders will be excluded.
- Toddlers with a history of infant reflux will not be excluded. The PI will make this distinction after a detailed history and record review.
- Families who do not speak English or Spanish in the home.
- Toddlers with suspected malabsorption or conditions that increased metabolic demands such as congenital heart defects.
- Toddlers who have a diagnosed allergy to cow's milk.
The PI will use their clinical discretion to ascertain patient eligibility.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Growing Up Formula (GUF)
|
Enfagrow® Neuropro Toddler Nutritional Drink to be consumed per day (equivalent to 40 mL per kg, rounded to the nearest ounce)
|
|
Active Comparator: Standard Nutritional Supplement (NS)
|
Pediasure® Grow & Gain Protein Shake for Kids to be consumed per day (equivalent to 40 mL per kg, rounded to the nearest ounce)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dietary intake from solid foods - Total proteins in grams
Time Frame: At baseline
|
|
At baseline
|
|
Dietary intake from solid foods - Total grains in grams
Time Frame: At baseline
|
|
At baseline
|
|
Dietary intake from solid foods - Total vegetables in cups
Time Frame: At baseline
|
|
At baseline
|
|
Dietary intake from solid foods - Total proteins in grams
Time Frame: At 3 months
|
|
At 3 months
|
|
Dietary intake from solid foods - Total grains in grams
Time Frame: At 3 months
|
|
At 3 months
|
|
Dietary intake from solid foods - Total vegetables in cups
Time Frame: At 3 months
|
|
At 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Secondary Outcomes Measures Related to Growth and Nutrition
Time Frame: Change from baseline to 3 months
|
Change in micronutrient status between baseline and month 3 as assessed through circulating micronutrient status, measured by laboratory assessment: CBC, Ferritin, sed rate, zinc, DHA, and vitamin D
|
Change from baseline to 3 months
|
|
Secondary Outcomes Measures Related to Growth and Nutrition -- Weight gain
Time Frame: Change from baseline to 3 months
|
Nutrition status assessment - Change in weight Weight gain: catch up growth is defined by weight gain of >6 g per day[
|
Change from baseline to 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Liliane Diab, MD, Children's Hospital Colorado
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 27, 2021
Primary Completion (Actual)
November 1, 2024
Study Completion (Actual)
December 1, 2024
Study Registration Dates
First Submitted
September 3, 2021
First Submitted That Met QC Criteria
October 8, 2021
First Posted (Actual)
October 22, 2021
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
February 13, 2025
Last Verified
February 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20-3082
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Toddlers 12-36 Months of Age With Mild or Moderate Malnutrition
-
Sanford HealthNational Ataxia Foundation; Beyond Batten Disease Foundation; Pitt Hopkins Research... and other collaboratorsRecruitingMitochondrial Diseases | Retinitis Pigmentosa | Myasthenia Gravis | Eosinophilic Gastroenteritis | Moyamoya Disease | Multiple System Atrophy | Leiomyosarcoma | Leukodystrophy | Anal Fistula | Spinocerebellar Ataxia Type 3 | Friedreich Ataxia | Kennedy Disease | Lyme Disease | Hemophagocytic Lymphohistiocytosis | Spinocerebellar... and other conditionsUnited States, Australia
Clinical Trials on Enfagrow® Neuropro Toddler Nutritional Drink
-
Fondazione IRCCS Policlinico San Matteo di PaviaIRCCS Ospedale San RaffaeleNot yet recruiting